nonlinear mixed effects modeling nonmem v7.3 (ICON plc)
90
Structured Review
ICON plc
nonlinear mixed effects modeling nonmem v7.3
Nonlinear Mixed Effects Modeling Nonmem V7.3, supplied by ICON plc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nonmem+v7%2E3/nonlinear+mixed+effects+modeling+software+nonmem+version+7+4+4/pm34347883-92-6-11
Average 90 stars, based on 1 article reviews
Nonlinear Mixed Effects Modeling Nonmem V7.3, supplied by ICON plc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nonmem+v7%2E3/nonlinear+mixed+effects+modeling+software+nonmem+version+7+4+4/pm34347883-92-6-11
Average 90 stars, based on 1 article reviews
nonlinear mixed effects modeling nonmem v7.3 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Population Pharmacokinetics of Vancomycin in Pediatric Extracorporeal Membrane Oxygenation* Article Snippet: Copyright © 2018 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.. Unauthorized reproduction of this article is prohibited Pediatric Critical Care Medicine www.pccmjournal.org 973 Objectives: Describe the pharmacokinetics of vancomycin in pediatric patients undergoing extracorporeal membrane oxygenation and provide dosing recommendations to attain an area under the curve for 24 hours greater than 400 in this population.. Design: Retrospective, population pharmacokinetic analysis. Article Title: A phase 1b study of the Akt-inhibitor MK-2206 in combination with weekly paclitaxel and trastuzumab in patients with advanced HER2-amplified solid tumor malignancies. Article Snippet: Purpose Akt plays a key role in the aggressive pathogenesis of HER2? malignancies, suggesting that Akt-inhibitors may be of therapeutic value in the treatment of HER2? tumors.. Preclinical studies demonstrate synergy between MK-2206, a selective allosteric Akt-inhibitor, with paclitaxel and trastuzumab.. We aimed to evaluate the safety of this combination in patients with HER2? malignancies. Article Title: Fosphenytoin Population Pharmacokinetics in the Acutely Ill Pediatric Population* Article Snippet: Copyright © 2018 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.. Unauthorized reproduction of this article is prohibited Copyright © 2018 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.. Unauthorized reproduction of this article is prohibited Neurocritical Care Article Title: CYP2C19 Phenotype and Body Weight-Guided Voriconazole Initial Dose in Infants and Children after Hematopoietic Cell Transplantation. Article Snippet: We performed popPK analysis of voriconazole using nonlinear mixedeffects modeling in Article Title: Population pharmacokinetics of mycophenolic acid in Mexican patients with lupus nephritis. Article Snippet: Background: Mycophenolic acid (MPA) is an effective oral immunosuppressive drug used to treat lupus nephritis (LN), which exhibits large pharmacokinetic variability.. This study aimed to characterize MPA pharmacokinetic behaviour in Mexican LN patients and to develop a population pharmacokinetic model which identified factors that influence MPA pharmacokinetic variability.. Methods: Blood samples from LN patients treated with mycophenolate mofetil (MMF) were collected pre dose and up to six hours post dose. |